Pseudophakic Macular Edema
📧 Sign up to get email alerts when something new happens for Pseudophakic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME) [Phase 3]
Phase 3 clinical trial evaluating intravitreal bevacizumab (Avastin) for pseudophakic macular edema was withdrawn.